Related Experiment Video
Updated: Jun 16, 2026
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
The treatment of solid tumors by alpha emitters released from (224)Ra-loaded sources-internal dosimetry analysis
1Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
Physics in Medicine and Biology
|February 4, 2010
Summary
Diffusing alpha-emitters radiation therapy (DART) shows promise for treating solid tumors. Safety assessments indicate that DART can treat large tumors without exceeding organ tolerance doses, minimizing risks to distant organs.
Area of Science:
- Radiation oncology
- Medical physics
- Nuclear medicine
Background:
- Diffusing alpha-emitters radiation therapy (DART) is an emerging brachytherapy technique using radium-224 sources to deliver targeted alpha particle radiation to solid tumors.
- Preclinical studies have shown DART's efficacy in treating various cancers, paving the way for clinical trials.
Purpose of the Study:
- To evaluate the safety of DART concerning radiation dose to distant organs.
- To assess potential risks associated with lead-212 (a decay product) leakage from the tumor via the bloodstream.
Main Methods:
- Utilized biokinetic modeling to simulate the dispersion and uptake of lead-212.
- Coupled biokinetic calculations with internal dose assessments to estimate organ radiation exposure.
- Modeled typical DART parameters, including source spacing and radium-224 activity density.
Main Results:
- Identified kidneys and red bone marrow as the dose-limiting organs for DART.
- Predicted that DART can safely treat tumors weighing up to several hundred grams.
- Calculations suggest that typical treatment parameters will not lead to exceeding organ tolerance doses.
Conclusions:
- DART demonstrates a favorable safety profile for treating solid tumors, with manageable risks to distant organs.
- The study provides crucial data for optimizing DART protocols and ensuring patient safety in upcoming clinical trials.
- Further research and clinical validation are essential to confirm the long-term safety and efficacy of DART.
Related Concept Videos
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
03:23Types of Radioactivity
The most common types of radioactivity are α decay, β decay, γ decay, neutron emission, and electron capture.
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay: